87 related articles for article (PubMed ID: 10422282)
1. [Targeted immunotherapy for malignant tumors].
Turuo T
Rinsho Ketsueki; 1999 Jun; 40(6):476-9. PubMed ID: 10422282
[No Abstract] [Full Text] [Related]
2. The role of caspase-8 in resistance to cancer chemotherapy.
Kim PK; Mahidhara R; Seol DW
Drug Resist Updat; 2001 Oct; 4(5):293-6. PubMed ID: 11991682
[TBL] [Abstract][Full Text] [Related]
3. [Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].
Yachi A; Imai K; Hirata H; Hishikawa N
Nihon Rinsho; 1989 Jun; 47(6):1391-5. PubMed ID: 2475654
[No Abstract] [Full Text] [Related]
4. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
Wu GS; Ding Z
Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
[TBL] [Abstract][Full Text] [Related]
5. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
Crawford KW; Bowen WD
Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394
[TBL] [Abstract][Full Text] [Related]
6. Targeted toxins.
Frankel AE; Kreitman RJ; Sausville EA
Clin Cancer Res; 2000 Feb; 6(2):326-34. PubMed ID: 10690507
[TBL] [Abstract][Full Text] [Related]
7. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
8. [Prospects for improving antibody therapy for carcinoma].
Liu XY
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1145-6. PubMed ID: 15387972
[No Abstract] [Full Text] [Related]
9. Drug-immunoglobulin conjugates as targeted therapeutic systems.
Mitra AK; Ghosh MK
Targeted Diagn Ther; 1990; 3():141-87. PubMed ID: 2131009
[No Abstract] [Full Text] [Related]
10. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
[TBL] [Abstract][Full Text] [Related]
11. Motexafin gadolinium induces mitochondrially-mediated caspase-dependent apoptosis.
Chen J; Ramos J; Sirisawad M; Miller R; Naumovski L
Apoptosis; 2005 Oct; 10(5):1131-42. PubMed ID: 16151646
[TBL] [Abstract][Full Text] [Related]
12. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
[TBL] [Abstract][Full Text] [Related]
13. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.
Fulda S; Debatin KM
Oncogene; 2002 Apr; 21(15):2295-308. PubMed ID: 11948413
[TBL] [Abstract][Full Text] [Related]
14. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
Fulda S; Wick W; Weller M; Debatin KM
Nat Med; 2002 Aug; 8(8):808-15. PubMed ID: 12118245
[TBL] [Abstract][Full Text] [Related]
15. Prospective strategies to enforce selectively cell death in cancer cells.
Blagosklonny MV
Oncogene; 2004 Apr; 23(16):2967-75. PubMed ID: 15077157
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
17. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
18. [Advances in studies on inhibitor of apoptosis proteins and cancer therapy].
Wang XH; Fu LW
Yao Xue Xue Bao; 2006 Feb; 41(2):103-7. PubMed ID: 16671537
[No Abstract] [Full Text] [Related]
19. Apoptosis is critical for drug response in vivo.
Schmitt CA; Lowe SW
Drug Resist Updat; 2001 Apr; 4(2):132-4. PubMed ID: 11512522
[No Abstract] [Full Text] [Related]
20. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
